My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2015
TOP STORIES
Drug Company Reverses 5,000% Increase in Drug Price
Member Concerns Spur IDSA/HIVMA Action
IDSA and HIVMA recently challenged a sudden price increase for pyrimethamine, a generic drug used to treat toxoplasmosis. Turing Pharmaceuticals acquired the drug in mid-August and increased the price from $13.50 to $750 per tablet. After hearing concerns from IDSA and HIVMA members, IDSA President Stephen Calderwood, MD, FIDSA, and HIVMA Chair Adaora Adimora, MD, FIDSA, wrote to Turing officials urging the company to revise its pricing strategy.

The jump in the drug price caught the attention of policy-makers and the media, which led to a groundswell of media requests for interviews with HIVMA spokespersons resulting in over 100 news stories quoting HIVMA and IDSA experts, including pieces in the New York Times, USA Today, The Washington Post and NBC News. Immediately following the news coverage, Turing announced that it would lower the price of the drug within a few weeks. The new price has not been disclosed.  



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
CDC Investigates Multistate Outbreak of Listeriosis Linked to Soft Cheeses
POLICY AND ADVOCACY
IDSA Leaders Appointed to New Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
IDSA and HIVMA “Rally for Medical Research”
S-FAR Holds Strategy Meeting with over 50 Partner Organizations
GLOBAL ID
Science Speaks Reports on New HIV and TB Resources
EDUCATION AND RESOURCES
IDSA Education and Research Foundation to Host Donors’ Lounge at IDWeek 2015
Thank You—We Couldn't Have Done it Without You
IDSA Education and Research Foundation Announces New Award in Memory of Robert C. Moellering, MD, FIDSA
ASP Announces Accreditation Seminar
YOU AND YOUR COLLEAGUES
Member Report
FROM THE PRESIDENT
From Ebola, Antibiotic Resistance and ABIM to Strategic Planning…A Year in Review
TOP STORIES
Bipartisan Antibiotic and Diagnostic Tax Credit Bill Introduced in Congress
Drug Company Reverses 5,000% Increase in Drug Price
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.